2011
DOI: 10.1016/j.brainres.2011.07.041
|View full text |Cite
|
Sign up to set email alerts
|

Tobacco smoke diminishes neurogenesis and promotes gliogenesis in the dentate gyrus of adolescent rats

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
17
1

Year Published

2012
2012
2021
2021

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 30 publications
(18 citation statements)
references
References 78 publications
0
17
1
Order By: Relevance
“…Factors possibly affecting group variability were nicotine and benzodiazepine use. In the control group, nicotine-exposed subjects had fewer NPCs in the whole DG and pes , according to the literature in lower mammals (6,71). Nicotine effect could not be tested in antidepressant-treated MDDs, which had only one smoker; untreated MDDs had double the number of non-smokers than controls, possibly blunting control-MDD differences in NPCs.…”
Section: Discussionmentioning
confidence: 62%
“…Factors possibly affecting group variability were nicotine and benzodiazepine use. In the control group, nicotine-exposed subjects had fewer NPCs in the whole DG and pes , according to the literature in lower mammals (6,71). Nicotine effect could not be tested in antidepressant-treated MDDs, which had only one smoker; untreated MDDs had double the number of non-smokers than controls, possibly blunting control-MDD differences in NPCs.…”
Section: Discussionmentioning
confidence: 62%
“…Embryonic neural progenitors have nicotinic cholinergic receptors (Atluri et al 2001; Schneider et al 2002) but nicotine does not show any marked antiproliferative or apoptotic effects even at concentrations up to 100 μM (Culbreth et al 2012). In contrast, nicotine does elicit apoptosis in undifferentiated stem cells (Berger et al 1998), and impairs neurogenesis in the adolescent or adult hippocampus (Bruijnzeel et al 2011; Cho and Kim 2010). Contrarily, nicotine increases proliferation in induced pluripotent stem cells (Ishizuka et al 2012)!…”
Section: Discussionmentioning
confidence: 99%
“…VLNTX downregulates activity at the mu-opioid receptor (Mannelli et al, 2004) that is selectively involved with dopamine response to hedonic stimuli (Wise, 2008), as well as to smoking and tobacco reinforcement (Domino et al, 2012;Liu & Jernigan, 2011). Clonidine moderates positive and negative smoking reinforcement through alpha-2-adrenergic agonism and GABA(B) receptor modulation (Bruijnzeel et al, 2011;Vlachou et al, 2011), though its clinical use is limited by orthostatic hypotension (Herman & Sofuoglu, 2010). A synergistic action on cigarette craving and smoking would explain the stronger efficacy of VLNTX + clonidine than each medication separately and allow use of lower doses of each drug, with reduced adverse events.…”
Section: Discussionmentioning
confidence: 99%